193 related articles for article (PubMed ID: 22705100)
1. Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.
Yong JH; Beca J; McGowan T; Bremner KE; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):521-31. PubMed ID: 22705100
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
[TBL] [Abstract][Full Text] [Related]
3. A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer.
Hummel SR; Stevenson MD; Simpson EL; Staffurth J
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e159-67. PubMed ID: 23040143
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
[TBL] [Abstract][Full Text] [Related]
6. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
Carter HE; Martin A; Schofield D; Duchesne G; Haworth A; Hornby C; Sidhom M; Jackson M
Radiother Oncol; 2014 Aug; 112(2):187-93. PubMed ID: 24929702
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
8. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.
Zemplényi AT; Kaló Z; Kovács G; Farkas R; Beöthe T; Bányai D; Sebestyén Z; Endrei D; Boncz I; Mangel L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26782759
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
12. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
[TBL] [Abstract][Full Text] [Related]
14. Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?
Konski A; Speier W; Hanlon A; Beck JR; Pollack A
J Clin Oncol; 2007 Aug; 25(24):3603-8. PubMed ID: 17704408
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer.
Sher DJ; Parikh RB; Mays-Jackson S; Punglia RS
Am J Clin Oncol; 2014 Jun; 37(3):215-21. PubMed ID: 23275277
[TBL] [Abstract][Full Text] [Related]
16. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Shimizuguchi T; Nihei K; Okano T; Machitori Y; Ito K; Karasawa K
Int J Clin Oncol; 2017 Apr; 22(2):373-379. PubMed ID: 27778117
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for anal cancer.
Hodges JC; Beg MS; Das P; Meyer J
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):773-83. PubMed ID: 24726392
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
19. Rectal dose reduction with IMRT for prostate radiotherapy.
Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE
J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012
[TBL] [Abstract][Full Text] [Related]
20. Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy.
Yang R; Xu S; Jiang W; Xie C; Wang J
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):706-12. PubMed ID: 19713087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]